Mersana Therapeutics snaps up $33 mln
Cambridge, Massachusetts-based biotech company Mersana Therapeutics has closed $33 million in Series C financing. Wellington Management Company led the round with participation from other investors that included Cormorant Asset Management, Arrowpoint Partners, Takeda Pharmaceutical Company Limited, New Enterprise Associates and Rock Springs Capital.
16 June 2016•1 min read
